Maverick Capital

This global investment firm focuses on long/short hedged equity strategies, investing in private companies with disruptive business models or technologies.

ActiveVenture Capital

Updated: Dec 5, 2025 ·

About

Maverick Capital is a global investment firm with offices in New York, San Francisco, London, Hong Kong, Philadelphia and Dallas. Maverick's investment team seeks to grow and preserve capital for its investors, primarily through a long/short hedged equity strategy. Since the Firm's inception in 1993, Maverick has strategically invested in private companies that represent disruptive business models or technologies. Maverick actively partners with portfolio company teams through the deployment of its resources and deep fundamental research capabilities to help entrepreneurs build their businesses.

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Oct 1, 2025	EvenUp	$150.0M Series E	—	645 Ventures, Gautam Gupta, Kevin Hartz, Accel, Alt Capital, Andreessen Horowitz, Bain Capital Ventures, Bessemer Venture Partners, Bond, DCM, DTCP, Jenny Fielding, Scott Hartley, Forerunner Ventures, Foundry Group, Greylock, High Alpha, Insight Partners, Lightspeed Venture Partners, NFX, Ribbit Capital, SignalFire, Thrive Capital, Tribe Capital, Underscore VC, Y Combinator, Aaron Levie, Allison Pickens (Allison Pickens Ventures), Frederic Kerrest, Gokul Rajaram, Howie Liu, Marc Benioff, Matt Macinnis, Mike Liu, Mike Vernal, Scott Belsky
Sep 1, 2025	Daymark Health	$20.0M Series A	—	Alpha Venture Partners, Sandbox Industries
Sep 1, 2025	Notable	$6.0M Series A	—	F-Prime Capital Partners, Greylock, Oak HC/FT, Second Century Ventures, S J
Aug 1, 2025	Tote.ai	$23.0M Venture Round	—	Alchemist Accelerator, Asset Management Ventures, Storm Ventures, Visionaire Ventures
Jul 1, 2025	PlayerZero	$5.0M Seed	—	645 Ventures, 8VC, Abstract Ventures, Bennett Siegel, Kevin Hartz, Adverb Ventures, Alchemy Ventures, Alt Capital, Ben Taft's Genius Ventures, Citi Ventures, Craft Ventures, DFJ, DST Global, Expa, Felicis Ventures, First Round Capital, Forerunner Ventures, Foundation Capital, Foundry Group, Fuel Capital, Green Bay Ventures, Greylock, High Alpha, Intel Capital, LGF, Liquid 2 Ventures, Maniv Mobility, Matrix, Nyca Partners, Radical Ventures, Scribble Ventures, Seven Seven Six, SignalFire, South Park Commons, SV Angel, Thayer Ventures, Thrive Capital, Toyota Ventures, Two Sigma Ventures, Uncork Capital, Underscore VC, Weekend Fund, WndrCo LLC, Y Combinator, Amjad Masad, Austin Ogilvie, Chris Bennett, Daniel Kan, Deborah Liu, DJ Patil, Drew Houston, Dylan Field, Eric Futoran, Evan Moore, Fidji Simo, Guillaume Luccisano, Guillermo Rauch, Howie Liu, Jacob Kerzner, Jason Kay, Justin Mateen, Kevin Lin, Marc Benioff, Mark Pincus, Mike Abbott, Mike Liu, Mike Vernal, Nate Matherson, Nitay Joffe, Prescott Watson, Quinn Slack, Shishir Mehrotra, Stewart Butterfield, Tobias Lutke, Yan-David Erlich
Jun 1, 2025	Mandolin	$40.0M Series A	—	645 Ventures, CRV, Fika Ventures, Foundry Group, Goat Capital, Greylock, High Alpha, Index Ventures, Khosla Ventures, Kleiner Perkins, Saga, Sequoia Capital, SignalFire, The Community Fund, Thrive Capital, Underscore VC, Balaji Srinivasan, Ding Zhou, Guillermo Rauch, Karim Atiyeh, Marc Benioff, Michael Stoppelman, Mike Liu, Scott Belsky, Steve King, Varsha Rao
Apr 1, 2025	Nourish	$70.0M Series B	—	Alpha Venture Partners, Andreessen Horowitz, TJ Nahigian, BoxGroup, Buckley Ventures, Byers Capital, General Catalyst, Frederique Dame, Index Ventures, Sandbox Industries, Gordon Wintrob, Nikhil Krishnan, Zak Kukoff
Apr 1, 2025	Daymark Health	$12.0M Seed	—	Gautam Gupta, Alpha Venture Partners
Feb 1, 2025	Fifteenth	$8.0M Seed	—	01 Advisors, 20VC, A* Capital (A Star Capital), Accel, AirAngels, Coinbase Ventures, FJ Labs, Jude Gomila Rolling Fund, Sequoia Capital, Y Combinator, Aston Motes, Bobby Goodlatte, Charlie Cheever, Christina Cacioppo, Claire Hughes Johnson, Dylan Field, Immad Akhund, Jeff Chang, Julia DeWahl, Koen Bok, Lauren Loktev, Marc McCabe, Robert Gentz, Stewart Butterfield, Tikhon Bernstam
Jan 1, 2025	Aligned Marketplace	$3.0M Seed	—	A* Capital (A Star Capital), Advent Life Sciences, Draper Associates, F-Prime Capital Partners, Global Ventures, Pear VC, Questa Capital, Curtis Chambers
Oct 1, 2024	Healthie	$23.0M Series B	—	2048 Ventures, BoxGroup, Curie.Bio, Index Ventures, Lazerow Ventures, Stellar Capital, Susa Ventures, Techstars, Thrive Capital, Gautam Gupta
Oct 1, 2024	EvenUp	$140.0M Series D	—	645 Ventures, Gautam Gupta, Kevin Hartz, Accel, Alt Capital, Andreessen Horowitz, Bain Capital Ventures, Bessemer Venture Partners, Bond, DCM, DTCP, Jenny Fielding, Scott Hartley, Forerunner Ventures, Foundry Group, Greylock, High Alpha, Insight Partners, Lightspeed Venture Partners, NFX, Ribbit Capital, SignalFire, Thrive Capital, Tribe Capital, Underscore VC, Y Combinator, Aaron Levie, Allison Pickens (Allison Pickens Ventures), Frederic Kerrest, Gokul Rajaram, Howie Liu, Marc Benioff, Matt Macinnis, Mike Liu, Mike Vernal, Scott Belsky
Sep 1, 2024	Centivo	$75.0M Venture Round	—	B Capital Group, Convective Capital, F-Prime Capital Partners, GPO Fund, Moxxie Ventures, Powerhouse Ventures, Key Compton, Yumin Choi
Jul 1, 2024	Spear Bio	$45.0M Series A	—	ARCH Venture Partners, Foresite Capital, Scott Gottlieb
Jun 1, 2024	Fizz	$14.0M Seed	—	6th Man Ventures, Active Capital, Alt Capital, ATX Venture Partners, Canaan Partners, Comal Ventures, DFJ, Founders Co-op, Indicator Ventures, Kleiner Perkins, KRM Interests LLC, Lux Capital, Menlo Ventures, Mouro Capital, Necessary Ventures, Next Coast Ventures, Picus Capital, Precursor Ventures, QED Investors, Red Swan Ventures, Sunset Ventures, XStarPartners, Y Combinator, Adam Marchick, Andy Rubin, Brian Sugar, hugo angelmar, Rajiv Bala, Ravi Grover, Sri Batchu
May 1, 2024	MakersHub	$2.0M Seed	—	6th Man Ventures, DFJ, Founders Co-op, Kleiner Perkins, KRM Interests LLC, Menlo Ventures, Mouro Capital, Necessary Ventures, QED Investors, XStarPartners, Adam Marchick, Andy Rubin, hugo angelmar, Ravi Grover, Sri Batchu
Apr 1, 2024	Aligned Marketplace	$8.0M Seed	—	Advent Life Sciences, Draper Associates, F-Prime Capital Partners, Global Ventures, Questa Capital, Curtis Chambers
Mar 1, 2024	PocketHealth	$33.0M Series B	—	Advent Life Sciences, Draper Associates, F-Prime Capital Partners, Global Ventures, Questa Capital, Curtis Chambers
Mar 1, 2024	Nourish	$35.0M Series A	—	8VC, 9Yards Capital, Adverb Ventures, Afore Capital, Aleph VC, Alpha Venture Partners, Amino Capital, Andreessen Horowitz, TJ Nahigian, Benchmark, BoxGroup, Broadway Angels, Buckley Ventures, Byers Capital, Craft Ventures, CRV, Data Tech Fund, Electric Capital, Fika Ventures, General Catalyst, Frederique Dame, Index Ventures, IVP, Liquid 2 Ventures, NFX, Passion Capital, Sandbox Industries, SignalFire, Spark Capital, The Community Fund, The House Fund, Thrive Capital, WndrCo LLC, Akash Garg, Amr Awadallah, Charlie Songhurst, Ding Zhou, George Hu, Gordon Wintrob, Henry de Zoete, Ian Hogarth, Joshua Schachter, Michael Stoppelman, Mike Vernal, Nikhil Krishnan, Othman Laraki, Rob Solomon, Steve Chen, Steve King, Sue Xu, Vishal Makhijani, Zak Kukoff
Feb 1, 2024	Oula Health	$28.0M Series B	—	8VC, Alumni Ventures, Revolution, XFactor Ventures, Y Combinator, Anne Wojcicki
Jul 1, 2023	HumanFirst	$4.0M Seed	—	Allos Ventures, Arkitekt Ventures, August Capital, AV8 Ventures, Boldstart Ventures, Boost VC, Curie.Bio, Founder Collective, Fuel Capital, High Alpha, Lux Capital, Metanoia, Moxxie Ventures, Operator Partners, Revolution, Scalar Capital, SignalFire, SNR, SV Angel, Ade Olonoh, Alice Zhang, Ashley Larson, Bradley Horowitz, Curtis Lee, Elliott Cohen, Howie Liu, Leah Busque, Tim Kendall
May 1, 2023	Legacy	$25.0M Series B	—	B Capital Group, F-Prime Capital Partners, GPO Fund, Matrix, Y Combinator, Key Compton
Feb 1, 2023	Yodawy	$16.0M Series B	—	Advent Life Sciences, Canyon Creek, Draper Associates, DX Ventures, F-Prime Capital Partners, Global Ventures, NEO, One Planet Group, Pitbull Ventures, Questa Capital, Think + Ventures, YLEM, Curtis Chambers, Farhad Mohit, Russell Cook, Scott Banister
Jan 1, 2023	NOCD	$34.0M Series B	—	7wire Ventures, Advent Life Sciences, Draper Associates, F-Prime Capital Partners, General Catalyst, Global Ventures, Latitud, Picus Capital, Questa Capital, Curtis Chambers
Jan 1, 2023	Sleepagotchi	$4.0M Seed	—	6th Man Ventures, DFJ, Founders Co-op, Kleiner Perkins, KRM Interests LLC, Menlo Ventures, Mouro Capital, Necessary Ventures, QED Investors, XStarPartners, Adam Marchick, Andy Rubin, hugo angelmar, Ravi Grover, Sri Batchu

Financial History

Total Raised

N/A

Valuation

N/A

Leadership Team

Key people at Maverick Capital.

Senior Portfolio Manager

Leadership Team

Key people at Maverick Capital.

Senior Portfolio Manager

Deep Dive

High-Level Overview

Maverick Capital is a global investment firm specializing in long/short hedged equity strategies, primarily focusing on public equities with selective investments in private companies exhibiting disruptive business models or technologies. Its mission centers on generating superior risk-adjusted returns through disciplined, bottom-up fundamental analysis, emphasizing management quality and capital allocation efficiency. Key sectors include technology, healthcare, biotechnology, media, and consumer discretionary. Maverick Capital’s active engagement in venture capital since 2015, particularly in healthcare and biotech startups, positions it as an influential player in nurturing innovation within the startup ecosystem[1][2][3].

Origin Story

Founded in 1993 by Lee Ainslie, a former protégé ("Tiger Cub") of Julian Robertson at Tiger Management, Maverick Capital began with $38 million raised from the family of Texas entrepreneur Sam Wyly. Initially a traditional hedge fund focused on public equities, the firm evolved to diversify into young companies starting in 2004 and formally launched a venture capital fund in 2015. This evolution reflects a strategic broadening from purely public markets to include private investments, especially in sectors with high innovation potential such as healthcare and biotechnology[1][2].

Core Differentiators

Unique Investment Model: Combines long/short equity strategies with rigorous fundamental bottom-up analysis, focusing on management quality and capital allocation returns relative to cost of capital.
Network Strength: Deep relationships with management teams, valuing collaboration over interventionist approaches.
Track Record: Consistent compounded annual returns of approximately 13% from 1995 to 2014, with assets under management around $10.7 billion as of recent reports.
Operating Support: Active portfolio management with dynamic adjustments to holdings, including significant recent investments in major technology and media companies.
Venture Capital Expansion: Since 2015, strategic investments in startups, particularly in healthcare, biotech, and emerging technologies like AI hardware, exemplified by their 2024 investment in the AI startup 'io' founded by Jony Ive[1][2][3][4].

Role in the Broader Tech Landscape

Maverick Capital rides the trend of integrating traditional hedge fund strategies with venture capital investments, capitalizing on the convergence of public and private markets. The timing aligns with increased innovation cycles in technology and healthcare, where disruptive startups require patient capital and strategic guidance. Market forces such as rapid technological advancement, AI proliferation, and biotech breakthroughs favor firms like Maverick that blend deep fundamental analysis with venture exposure. Their influence extends by providing growth capital and strategic support to startups, thereby accelerating innovation and shaping emerging tech ecosystems[1][3].

Quick Take & Future Outlook

Looking ahead, Maverick Capital is poised to deepen its footprint in disruptive technologies, particularly artificial intelligence and biotechnology, leveraging its dual expertise in public and private markets. Trends such as AI hardware development, precision medicine, and digital transformation will likely shape its investment trajectory. The firm’s ability to adapt its long/short equity strategies alongside venture investments will be critical to sustaining superior returns and ecosystem influence. Maverick’s evolving role as both a hedge fund and venture investor uniquely positions it to capitalize on and contribute to the next wave of technological innovation[1][3].

Sources

High-Level Overview

Origin Story

Core Differentiators

Unique Investment Model: Combines long/short equity strategies with rigorous fundamental bottom-up analysis, focusing on management quality and capital allocation returns relative to cost of capital.
Network Strength: Deep relationships with management teams, valuing collaboration over interventionist approaches.
Track Record: Consistent compounded annual returns of approximately 13% from 1995 to 2014, with assets under management around $10.7 billion as of recent reports.
Operating Support: Active portfolio management with dynamic adjustments to holdings, including significant recent investments in major technology and media companies.
Venture Capital Expansion: Since 2015, strategic investments in startups, particularly in healthcare, biotech, and emerging technologies like AI hardware, exemplified by their 2024 investment in the AI startup 'io' founded by Jony Ive[1][2][3][4].